ibudilast has been researched along with Cancer of Gastrointestinal Tract in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
" A population pharmacokinetic approach was used to determine oxaliplatin and 5-fluorouracil pharmacokinetics with and without ibudilast." | 2.94 | Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer. ( Blinman, PL; Dhillon, HM; Galettis, P; McLachlan, AJ; Proschogo, N; Reuter, SE; Teng, C; Vardy, JL, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Teng, C | 1 |
Reuter, SE | 1 |
Blinman, PL | 1 |
Dhillon, HM | 1 |
Galettis, P | 1 |
Proschogo, N | 1 |
McLachlan, AJ | 1 |
Vardy, JL | 1 |
1 trial available for ibudilast and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Female; Fluorouracil; Gastr | 2020 |